(Reuters) - The $2.3 trillion COVID-19 aid and spending package signed by U.S. President Donald Trump buoyed the stock and oil markets on Monday, while more countries detected their first cases of a new variant of the coronavirus.
DEATHS AND INFECTIONS * Eikon users, see COVID-19: MacroVitals here for a case tracker and summary of news.
* The distribution of an initial 200 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech across the European Union will be completed by September, a spokesman for the EU Commission said.
* Some German districts will not use the COVID-19 vaccine received over the weekend over the suspicion that the cold chain could have been interrupted during its delivery, a district administrators told Reuters TV.
* Russia’s first big international shipment of its vaccine - 300,000 doses sent to Argentina last week - consisted only of the first dose of the two-shot vaccine, which is easier to make than the second dose, sources told Reuters.
* Democrats in the U.S. Congress on Monday will try to push through expanded $2,000 pandemic relief payments for Americans after President Trump backed down from a fight with lawmakers that could have shut down the federal government.
* The U.S. Transportation Security Administration said it screened 1.28 million passengers at U.S. airports on Sunday, the highest number since mid-March, when the pandemic slashed travel demand.
* Brazilian Vice President Hamilton Mourao is taking the antimalarial drug hydroxychloroquine as part of an unproven treatment after contracting COVID-19, his office said.
* South Korean officials are vowing to speed up efforts to launch a public COVID-19 vaccination programme as the country announced it had detected its first cases of the virus variant linked to a rapid rise in infections in Britain.
* International visitors will be barred from entering Indonesia for a two-week period to try to keep out the potentially more contagious variant of the virus.
* A Chinese court handed down a four-year jail term to a citizen-journalist who reported from the central city of Wuhan at the peak of this year’s outbreak on the grounds of “picking quarrels and provoking trouble”, her lawyer said.
* Authorities in Kazakhstan said they had signed a preliminary agreement with Pfizer to potentially buy the vaccine it developed with its partner BioNTech.
MIDDLE EAST AND AFRICA
* Lebanon has secured about 2 million doses of Pfizer-BioNTech’s vaccine, which will cover 20% of the country’s nationals, the health minister said.
* Saudi Arabia’s interior ministry extended a ban on entry to the kingdom by air, land and sea for another week amid concerns over the variant of the virus.
* South Africa’s total infections crossed a million on Sunday, days after another new variant of virus - which UK officials have said appears to have mutated further than the variant in Britain - was confirmed to be present in the country.
* Russia will begin trials of an antibody treatment for COVID-19 patients next year, according to the head of the Moscow institute that developed the country’s first vaccine against the disease, Sputnik V.
* The Serum Institute of India, the local maker of the Oxford/AstraZeneca coronavirus vaccine, said it expected the British and Indian governments to approve shots for emergency use within a few days.
* Novavax Inc has begun a large late-stage study of its experimental COVID-19 vaccine in the United States, the drug developer said.
* Global shares rose and U.S. bond yields ticked higher on Monday after President Trump signed a $2.3 trillion spending package and as investors continued to celebrate a last-minute trade deal clinched between Britain and the European Union. [MKTS/GLOB]
Compiled by Linda Pasquini and Veronica Snoj; Editing by Kirsten Donovan
Our Standards: The Thomson Reuters Trust Principles.